ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.110,38
-0,16%
S&P 500
5.667,20
0,64%
US Dollar vs BRL
5,4313
-0,31%
Bitcoin
64.967,90
0,18%
Brent Oil
83,255
-1,29%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nightstar Therapeutics Plc ADS (NITE)

  7. Nightstar Therapeutics Plc ADS (NITE) Notícias

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE
DataHoraFonteTítuloCódigoCompanhia
08/05/200910:52MarketwiredMaybachFinancial.com Posts Free Analyst Report on PBCT, MXIM, NITE and PALMNASDAQ:NITENightstar Therapeutics Plc ADS
06/05/200909:30PR Newswire (US)Knight Capital Group's NetDelta CDS Platform Announces Senior Operations and Sales AppointmentsNASDAQ:NITENightstar Therapeutics Plc ADS
04/05/200910:00PR Newswire (US)Knight Libertas Appoints Head of Global Emerging Markets Fixed Income Team, Adds Sales and Trading StaffNASDAQ:NITENightstar Therapeutics Plc ADS
01/05/200910:48PR Newswire (US)Knight Capital Group to Present at Barclays Capital Financial Services ConferenceNASDAQ:NITENightstar Therapeutics Plc ADS
22/04/200909:34Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NITENightstar Therapeutics Plc ADS
22/04/200908:30PR Newswire (US)Knight Capital Group Releases March 2009 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
22/04/200907:00PR Newswire (US)Knight Capital Group Announces Earnings From Continuing Operations of $0.33 per Diluted Share and Consolidated Earnings of $0.10NASDAQ:NITENightstar Therapeutics Plc ADS
21/04/200904:30PR Newswire (US)Knight Capital Group Launches European Algorithmic SuiteNASDAQ:NITENightstar Therapeutics Plc ADS
16/04/200909:30PR Newswire (US)Knight Libertas Appoints John C. Price as Managing DirectorNASDAQ:NITENightstar Therapeutics Plc ADS
14/04/200909:30PR Newswire (US)Knight Libertas Appoints Terran A. Miller as Director, Fixed Income ResearchNASDAQ:NITENightstar Therapeutics Plc ADS
03/04/200910:52MarketwiredTheFortuneFinancial.com Initializes Free Analyst Research on TNE, THOR, NITE and STSANASDAQ:NITENightstar Therapeutics Plc ADS
02/04/200917:51Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NITENightstar Therapeutics Plc ADS
17/03/200912:40Dow Jones NewsUPDATE: Nasdaq OMX Europe To Launch Pan-European 'Dark Pool'NYSE:NITEKnight Capital Group Inc. (Cl A)
13/03/200908:30PR Newswire (US)Knight Capital Group Releases February 2009 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
10/03/200917:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NITENightstar Therapeutics Plc ADS
13/02/200919:26Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NITENightstar Therapeutics Plc ADS
13/02/200910:30PR Newswire (US)Knight Capital Group Releases January 2009 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
09/02/200913:01Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NITENightstar Therapeutics Plc ADS
02/02/200921:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NITENightstar Therapeutics Plc ADS
28/01/200919:26Dow Jones NewsUPDATE:NYSE Euronext To Launch Europe Dark Pool Platform Feb 2NYSE:NITEKnight Capital Group Inc. (Cl A)
28/01/200919:19Dow Jones NewsCORRECT: NYSE Euronext Spokeswoman Made Comment Wed, Not ThursdayNYSE:NITEKnight Capital Group Inc. (Cl A)
28/01/200919:12Dow Jones NewsCORRECT: Deutsche Bank's Ticker Symbol Is DBNYSE:NITEKnight Capital Group Inc. (Cl A)
28/01/200916:41Dow Jones NewsNYSE Euronext To Launch European Dark Pool On Feb 2NYSE:NITEKnight Capital Group Inc. (Cl A)
23/01/200912:33MarketwiredWall Street News Alert Reports Friday's Stocks to Watch: WLGC! January 23, 2009NASDAQ:NITENightstar Therapeutics Plc ADS
22/01/200919:05PR Newswire (US)Knight Promotes Gary Katcher and Steven J. Sadoff to Executive Vice PresidentsNASDAQ:NITENightstar Therapeutics Plc ADS
22/01/200913:55MarketwiredBenchmarkJournal.com (Complimentary) Analyst Updates for IWOV, EBAY, ECLP and NITENASDAQ:NITENightstar Therapeutics Plc ADS
22/01/200910:30PR Newswire (US)Knight Capital Group Releases December 2008 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
22/01/200909:11PR Newswire (US)Knight Capital Group Announces Earnings of $0.89 Per Diluted Share for the Fourth Quarter 2008NASDAQ:NITENightstar Therapeutics Plc ADS
16/01/200920:15Dow Jones NewsDirect Edge Targets Fourth Quarter Exchange LaunchNYSE:NITEKnight Capital Group Inc. (Cl A)
12/01/200911:30PR Newswire (US)Knight Direct EMS Launches Complex Options Order Trading CapabilitiesNASDAQ:NITENightstar Therapeutics Plc ADS
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE

Seu Histórico Recente

BOV
HAGA3
HAGA ON
BOV
IBOV
Índice Bovespa
BOV
TELB4
TELEBRAS PN
BOV
AZEV4
AZEVEDO PN
BOV
GFSA3
GAFISA ON
BOV
AMER3
Americanas ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
COGN3
COGNA ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
VVEO3
CM Hospitalar ON
BOV
AMAR3
LOJAS MARISA ON
BOV
JFEN3
JOAO FORTES ON
BOV
GOLL4
GOL PN
BOV
HBOR3
HELBOR ON
BOV
BOBR4
BOMBRIL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados